Brady Christopher J, Garg Seema
Division of Ophthalmology, Department of Surgery, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Telemed J E Health. 2020 Apr;26(4):565-568. doi: 10.1089/tmj.2020.0011. Epub 2020 Mar 25.
Background:As the leading cause of vision loss in the United States, age-related macular degeneration (AMD) would seem to be amenable to interventions that increase access to screening and management services for patients. AMD poses several unique challenges for telemedicine, however. The disease lacks clinical consensus on the effectiveness and cost-effectiveness of screening the general population, and more complex imaging modalities may be required than for what has traditionally been used for diabetic retinopathy telehealth systems.
Methods:The current literature was reviewed to find clinical trials and expert consensus documents on the state-of-the-art of telemedicine for AMD.
Results:A range of feasibility studies have reported success with telemedicine strategies for AMD. Several investigators have reported experience with AMD screening and remote-monitoring systems as well as artificial intelligence applications.
Conclusions:There are currently no large-scale telemedicine programs for either screening or managing AMD, but new approaches to screening and managing the condition may allow for expansion of high-quality convenient care for an increasing patient population.
作为美国视力丧失的主要原因，年龄相关性黄斑变性（AMD）似乎适合采取干预措施，以增加患者获得筛查和管理服务的机会。然而，AMD给远程医疗带来了几个独特的挑战。对于筛查普通人群的有效性和成本效益，该疾病缺乏临床共识，并且可能需要比传统用于糖尿病视网膜病变远程医疗系统更复杂的成像方式。
回顾当前文献，以查找关于AMD远程医疗最新技术的临床试验和专家共识文件。
一系列可行性研究报告了AMD远程医疗策略的成功。几位研究人员报告了在AMD筛查和远程监测系统以及人工智能应用方面的经验。
目前尚无用于筛查或管理AMD的大规模远程医疗项目，但筛查和管理该疾病的新方法可能会为越来越多的患者群体提供高质量的便捷护理。
